Literature DB >> 27437924

Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.

Otavio Rizzi Coelho-Filho1,2,3, Ravi Shah4, Carlos Fernando Ramos Lavagnoli5, Jose Carlos Barros5, Tomas G Neilan6, Venkatesh L Murthy7,8, Pedro Paulo Martins de Oliveira5, Jose Roberto Matos Souza5, Elaine Soraya Barbosa de Oliveira Severino5, Karlos Alexandre de Souza Vilarinho5, Lindemberg da Mota Silveira Filho5, Jose Garcia6, Marc J Semigran6, Otavio Rizzi Coelho5, Michael Jerosch-Herold9,10, Orlando Petrucci5,11.   

Abstract

After orthotopic heart transplantation (OHT), the allograft undergoes characteristic alterations in myocardial structure, including hypertrophy, increased ventricular stiffness, ischemia, and inflammation, all of which may decrease overall graft survival. Methods to quantify these phenotypes may clarify the pathophysiology of progressive graft dysfunction post-OHT. We performed cardiac magnetic resonance (CMR) with T1 mapping in 26 OHT recipients (mean age 47 ± 7 years, 30 % female, median follow-up post-OHT 6 months) and 30 age-matched healthy volunteers (mean age 50.5 ± 15 years; LVEF 63.5 ± 7 %). OHT recipients had a normal left ventricular ejection fraction (LVEF 65.3 ± 11 %) with higher LV mass relative to age-matched healthy volunteers (114 ± 27 vs. 85.8 ± 18 g; p < 0.001). There was no late gadolinium enhancement in either group. Both myocardial extracellular volume fraction (ECV) and intracellular lifetime of water (τic), a measure of cardiomyocyte hypertrophy, were higher in patients post-OHT (ECV: 0.39 ± 0.06 vs. 0.28 ± 0.03, p < 0.0001; τic: 0.12 ± 0.08 vs. 0.08 ± 0.03, p < 0.001). ECV was associated with LV mass (r = 0.74, p < 0.001). In follow-up, OHT recipients with normal biopsies by pathology (ISHLT grade 0R) in the first year post-OHT exhibited a lower ECV relative to patients with any rejection ≥2R (0.35 ± 0.02 for 0R vs. 0.45 ± 0, p < 0.001). Higher ECV but not LVEF was significantly associated with a reduced rejection-free survival. After OHT, markers of tissue remodeling by CMR (ECV and τic) are elevated and associated with myocardial hypertrophy. Interstitial myocardial remodeling (by ECV) is associated with cellular rejection. Further research on the impact of graft preservation and early immunosuppression on tissue-level remodeling of the allograft is necessary to delineate the clinical implications of these findings.

Entities:  

Keywords:  Extracellular volume fraction; Fibrosis; Gadolinium-DTPA; Hypertrophy; Magnetic resonance imaging and orthotopic heart transplantation

Mesh:

Year:  2016        PMID: 27437924     DOI: 10.1007/s10554-016-0937-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  35 in total

1.  A methodology for analysing a repeated measures and survival outcome simultaneously.

Authors:  J Rochon; B W Gillespie
Journal:  Stat Med       Date:  2001-04-30       Impact factor: 2.373

2.  Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.

Authors:  Nobuyuki Shiba; Michael C Y Chan; Bernard W K Kwok; Hannah A Valantine; Robert C Robbins; Sharon A Hunt
Journal:  J Heart Lung Transplant       Date:  2004-02       Impact factor: 10.247

Review 3.  Experience with cyclosporine in heart transplantation.

Authors:  C Sivathasan
Journal:  Transplant Proc       Date:  2004-03       Impact factor: 1.066

Review 4.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

5.  Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection.

Authors:  Craig R Butler; AnaMaria Savu; Jeffrey A Bakal; Mustafa Toma; Richard Thompson; Kelvin Chow; Harris Wang; Daniel H Kim; Michael Mengel; Mark Haykowsky; Glen J Pearson; Padma Kaul; Ian Paterson
Journal:  J Heart Lung Transplant       Date:  2015-01-08       Impact factor: 10.247

Review 6.  State of the art: cardiac transplantation.

Authors:  Margot K Davis; Sharon A Hunt
Journal:  Trends Cardiovasc Med       Date:  2014-08-26       Impact factor: 6.677

7.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

8.  Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation.

Authors:  Kairav Vakil; Ziad Taimeh; Alok Sharma; Kashan Syed Abidi; Monica Colvin; Russell Luepker; Wayne C Levy; Selcuk Adabag
Journal:  Heart Rhythm       Date:  2014-07-15       Impact factor: 6.343

9.  Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin.

Authors:  Amy J Malhowski; Haider Hira; Sarah Bashiruddin; Rod Warburton; June Goto; Blanton Robert; David J Kwiatkowski; Geraldine A Finlay
Journal:  Hum Mol Genet       Date:  2011-01-06       Impact factor: 6.150

10.  Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.

Authors:  Otavio R Coelho-Filho; Ravi V Shah; Richard Mitchell; Tomas G Neilan; Heitor Moreno; Bridget Simonson; Raymond Kwong; Anthony Rosenzweig; Saumya Das; Michael Jerosch-Herold
Journal:  Circulation       Date:  2013-08-02       Impact factor: 29.690

View more
  9 in total

1.  Myocardial Fibrosis and Prognosis in Heart Transplant Recipients.

Authors:  Andrew Hughes; Osama Okasha; Afshin Farzaneh-Far; Felipe Kazmirczak; Prabhjot S Nijjar; Pratik Velangi; Mehmet Akçakaya; Cindy M Martin; Chetan Shenoy
Journal:  Circ Cardiovasc Imaging       Date:  2019-10-15       Impact factor: 7.792

2.  CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.

Authors:  Yating Yuan; Jie Cai; Yue Cui; Jing Wang; Osamah Alwalid; Xuehua Shen; Yukun Cao; Yan Zou; Bo Liang
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-28       Impact factor: 2.357

3.  Quantitative myocardial tissue characterization by cardiac magnetic resonance in heart transplant patients with suspected cardiac rejection.

Authors:  Robert J H Miller; Louise Thomson; Ryan Levine; Sadia J Dimbil; Jignesh Patel; Jon A Kobashigawa; Evan Kransdorf; Debiao Li; Daniel S Berman; Balaji Tamarappoo
Journal:  Clin Transplant       Date:  2019-09-25       Impact factor: 2.863

4.  Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation.

Authors:  Ryan S Dolan; Amir A Rahsepar; Julie Blaisdell; Kenichiro Suwa; Kambiz Ghafourian; Jane E Wilcox; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Allen S Anderson; Clyde W Yancy; Jeremy D Collins; James C Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2019-03-13

5.  Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.

Authors:  Seiko Ide; Eugenie Riesenkampff; David A Chiasson; Anne I Dipchand; Paul F Kantor; Rajiv R Chaturvedi; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-01       Impact factor: 5.364

6.  Dynamical Landscape of Heart Rhythm in Long-Term Heart Transplant Recipients: A Way to Discern Erratic Rhythms.

Authors:  Joanna Wdowczyk; Danuta Makowiec; Marcin Gruchała; Dorota Wejer; Zbigniew R Struzik
Journal:  Front Physiol       Date:  2018-04-09       Impact factor: 4.566

7.  Assessment of sympathetic reinnervation after cardiac transplantation using hybrid cardiac PET/MRI: A pilot study.

Authors:  Dietrich Beitzke; Alice Wielandner; Tim Wollenweber; Chrysoula Vraka; Verena Pichler; Keziban Uyanik-Uenal; Andreas Zuckermann; Andreas Greiser; Marcus Hacker; Christian Loewe
Journal:  J Magn Reson Imaging       Date:  2019-03-20       Impact factor: 4.813

8.  Pre-clinical left ventricular myocardial remodeling in patients with Friedreich's ataxia: A cardiac MRI study.

Authors:  Karen A G Takazaki; Thiago Quinaglia; Thiago D Venancio; Alberto R M Martinez; Ravi V Shah; Tomas G Neilan; Michael Jerosch-Herold; Otávio R Coelho-Filho; Marcondes C França
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

9.  Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.

Authors:  Kongkiat Chaikriangkrai; Muhannad Aboud Abbasi; Roberto Sarnari; Ryan Dolan; Daniel Lee; Allen S Anderson; Kambiz Ghafourian; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Jane E Wilcox; Julie A Blaisdell; Clyde W Yancy; James Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2020-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.